CRG’s Brian Englander sat down with Joe Catanese, CEO of Calyxo, to discuss the kidney stone market, his career, and how his team is working to change kidney stone treatment through its innovative technology, ultimately improving the quality of care for patients who suffer from kidney stones.
Headquartered in Pleasanton, California, Calyxo is a commercial-stage urology medical device company focused on transforming kidney stone removal procedures. The company, originally Kalera Medical, was formed in 2016 through IP licensed out of Massachusetts General Hospital. The company’s lead product, the CVAC Aspiration System, is a steerable vacuum used to aspirate stone fragments following the use of a laser during stone removal procedures. CVAC is the first steerable kidney stone removal system used during ureteroscopy procedures and received 510(k) clearance…
Share your email below to keep reading — it’s free.
Your information is secure. View our Privacy Policy.
